The latest research from Fore Pharma, Global Irritable Bowel Syndrome Clinical Trial Pipeline Highlights – 2021, provides most up-to-date information on key pipeline products in the global Irritable Bowel Syndrome market. It covers emerging therapies for Irritable Bowel Syndrome in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this research helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Research Scope:
- Products by Clinical Trial Stages: Irritable Bowel Syndrome pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
- Drug Mechanism Classes: Irritable Bowel Syndrome pipeline products by their dominant mechanism of action / drug class. This helps executives categorize products based on their drug class.
- Company: Irritable Bowel Syndrome pipeline products by developing company.
- Short-term Launch Highlights: Find out which Irritable Bowel Syndrome pipeline products will be launched in the US and Ex-US till 2026.
Summary of Contents:
– Irritable Bowel Syndrome phase 3 clinical trial pipeline products
– Irritable Bowel Syndrome phase 2 clinical trial pipeline products
– Irritable Bowel Syndrome phase 1 clinical trial pipeline products
– Irritable Bowel Syndrome preclinical research pipeline products
– Irritable Bowel Syndrome discovery stage pipeline products
– Irritable Bowel Syndrome pipeline products short-term launch highlights
Table of Contents
1. Irritable Bowel Syndrome Pipeline by Stages
2. Irritable Bowel Syndrome Phase 3 Clinical Trial Insights
3. Irritable Bowel Syndrome Phase 2 Clinical Trial Insights
4. Irritable Bowel Syndrome Phase 1 Clinical Trial Insights
5. Irritable Bowel Syndrome Preclinical Research Insights
6. Irritable Bowel Syndrome Discovery Stage Insights
7. Appendix
8. Research Methodology
List of Tables
Table 1: Irritable Bowel Syndrome Phase 3 Clinical Trials, 2021
Table 2: Irritable Bowel Syndrome Phase 2 Clinical Trials, 2021
Table 3: Irritable Bowel Syndrome Phase 1 Clinical Trials, 2021
Table 4: Irritable Bowel Syndrome Preclinical Research, 2021
Table 5: Irritable Bowel Syndrome Discovery Stage, 2021
List of Figures
Figure 1: Irritable Bowel Syndrome Pipeline Molecules by Clinical Trials Stage, 2021
Figure 2: Irritable Bowel Syndrome Phase 3 Clinical Trial Highlights, 2021
Figure 3: Irritable Bowel Syndrome Phase 2 Clinical Trial Highlights, 2021
Figure 4: Irritable Bowel Syndrome Phase 1 Clinical Trial Highlights, 2021
Figure 5: Irritable Bowel Syndrome Preclinical Research Highlights, 2021
Figure 6: Irritable Bowel Syndrome Discovery Stage Highlights, 2021
Format
Default dispatch format is PDF.
